IL18 and neoplasm: Thus, further investigation into the use of hUMSCs/IL-18 as vehicles of tumor therapy in vivo, including pilot clinical trials, and in combination with other therapies, such as surgery, chemotherapy, endocrine therapy and targeted therapy, is warranted.